Claes Wahlestedt
Co-Founder, Co-Chairman of Scientific Advisory Board & Consulting Chief Medical OfficerDr. Claes Wahlestedt, Ph.D. MD., is Advisor & Member of Advisory Board of Healthspan Capital. He served as Member of Scientific Advisory Board at Camp4 Therapeutics Corporation. He serves as the Director of Neuroscience Discovery at the Scripps Research Institute, Scripps, Florida. He is a Co-Founder of Jupiter Neurosciences, Inc. (formerly Jupiter Orphan Therapeutics, Inc.) and serves as its Consulting Chief Medical Officer and Co-Chairman of Scientific Advisory Board since January 1, 2016. He had been Board Member of Jupiter Neurosciences, Inc. (formerly Jupiter Orphan Therapeutics, Inc.) from January 1, 2016 to October 1, 2021. He has been an Adjunct Professor at the Department of Pharmacology and the Department of Biochemistry, McGill University from 1994 to 1997, Montreal, Canada since 1995. He served as Scientific Advisor at Atlantic International Corp. (formerly known as SeqLL Inc.) and serves as Chairman of Scientific Advisory Board. He co-founded CURNA, Inc. and served as its Consultant. He Co-Founded Epigenetix Inc. He founded Genordia AB. Prior to joining Scripps Florida in 2005, he was founding director of the Center for Genomics and Bioinformatics at the Karolinska Institute in Stockholm and was also Director of Genomics and Biotechnology with Pharmacia between 1997 to 2004 & Upjohn in Stockholm, Sweden. From 1993 to 1997, He served as an Assistant Professor at the Department of Neurology and Neuro-science, Cornell University. He served as Chairman of the Board and Director of Genordia AB. Since March 2011, he has served as the Leonard M. Miller Professor & Associate Dean for Therapeutic Innovation at the University of Miami Miller School of Medicine. From 2005 to March 2011, he was the founding Professor and Director of Neuroscience at The Scripps Research Institute in Florida. From 1997 to 2005, he was the Professor and Department Chair at Karolinska Institute in Stockholm, Sweden. From 1989 to 1993, he was the Assistant Professor of the Department of Neurology and Neurosciences at Cornell University Medical College in New York, NY. He serves as a Member of Scientific Advisory Board of PainCeptor Pharma Corporation. He serves as a Member of Scientific & Business Advisory Board of Systems Biology Worldwide Ltd. He served as Member of Scientific Advisory Board of Genizon BioSciences, Inc. Prof. Wahlestedt served as Director of Florida's Blood Centers, Inc. He served as Founding Director of Astrazeneca Research Center in Canada from 1994 to 1997 and in boards of numerous biotech companies. His research is focused on non-coding RNA and he has been a pioneer in the use of antisense RNA, siRNA and small molecules that target RNA. He is Director of the Center for Therapeutic Innovation, Leonard M. Miller School of Medicine, University of Miami. He is the author of over 300 papers in scientific journals, with over 45,000 citations. He is the author of more than 180 publications and is the holder of several patents. He holds an M.D. in Medicine and Ph.D. in Pharmacology from the University of Lund in 1986 and 1987 respectively and Post-doctoral training at Kyoto University, Japan and at Georgetown University, Washington DC, USA.
Positions
- Company NameJupiter Neurosciences, Inc.Stock CodeJUNSPositionCo-Founder, Co-Chairman of Scientific Advisory Board & Consulting Chief Medical OfficerColleagues
